Explore detailed financial insights for NSE: Mankind Pharma Limited, including share price, quarterly results, governance, and stock forecasts for 2025.

NSE: Mankind Pharma Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept

Stay informed with the latest announcements for Mankind, including updates on board meetings and corporate actions.

MANKIND
Mankind Pharma Limited - https://www.mankindpharma.com
Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. It also provides consumer healthcare products, such as condoms, pregnancy detection kits, emergency contraceptives, antacid powders, vitamin and mineral supplements, and anti-acne preparations. The company offers its products primarily under the Manforce, Prega News, Unwanted-72, Gas-O-Fas, Health OK, and AcneStar brand names. In addition, it engages in the trading and exporting of pharmaceutical and health care products; manufacturing of packing materials ayurvedic products, packing materials, bulk drugs, and consumer goods; real estate, leasing, and hospitality businesses; and provision of IT services. Mankind Pharma Limited was founded in 1986 and is based in New Delhi, India.

Mankind Pharma Limited Share Price Today

2,477.45
OPEN
2,534.10
HIGH
2,460.65
LOW
2,485.40
CLOSE
375 K
VOLUME
117,943 Cr
Market Cap
399475
Average Volume
Healthcare
Sector
NSI
Exchange

Mankind Pharma Limited Share Analysis & 2025 Insights

// -->

Investor Presentations

Date Description Download
SIP
Lumpsum
₹25,000
12%
10 Yr

Invested Amount: ₹

Estimated Returns: ₹

Total Value: ₹

NSE: MANKIND Stock Actions

Company
Symbol
ISIN
Subject
Ex Date
Face Value
Broadcast Date